Avandia Safety

Zoloft Lawsuit Information : Pregnancy Birth Defect Zoloft Attorney

8 December, 2011

The bad drug lawsuit attorneys at AvandiaRecallNews.com no longer are accepting new Avandia cases. We continue to help families affected by Zoloft birth defects.

Our lawyers are accepting and aggressively litigating nationwide Zoloft Lawsuit claims to collect damages for Zoloft birth defects.

Call us now at 800-845-6913 or click this link for Zoloft Lawsuit Information.

Let us help you and your child recover the Zoloft birth defects compensation you deserve.

Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia Lawsuit | Avandia News | Avandia Recall | Avandia Safety | Avandia Senate Report | Avandia Settlements | Avandia Side Effects | Avandia Warning | Congestive Heart Failure

Avandia heart attack, CHF and stroke risks higher, new study confirms

6 April, 2011

A new Avandia study has reached a familiar conclusion: Avandia poses a higher risk of heart attack, congestive heart failure (CHF) and death compared to its rival diabetes drug, Actos. The new research confirms the findings of earlier Avandia heart risks studies. Continue reading Avandia heart attack, CHF and stroke risks higher, new study confirms

Category: Avandia Cardiovascular Risk | Avandia Lawsuit | Avandia News | Avandia Safety | Avandia Settlements | Avandia Side Effects

FDA Avandia news conference: 2010 rosiglitazone restrictions

15 October, 2010

A FDA Avandia news conference was held on September 23, 2010 to announce the FDA decision on Avandia and for FDA drug safety officials to take questions from the media.

The following is a complete transcript of the news conference. FDA Commissioner Margaret Hamburg, FDA Principal Deputy Commissioner Joshua Sharfstein and Janet Woodcock, Director of the Center for Drug Evaluation and Research at FDA all were in attendance. Continue reading FDA Avandia news conference: 2010 rosiglitazone restrictions

Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia News | Avandia Recall | Avandia Safety | Avandia Warning

FDA Avandia heart attack news, Avandia critic reacts to FDA

8 October, 2010

In May 2007, Cleveland Clinic cardiologist Dr. Steven Nissen published an Avandia study in the New England Journal of Medicine that would mark a turning point for the diabetes drug Avandia.

Dr. Nissen found that Avandia use was linked to a 43% increased risk of heart attack. and has been a vocal critic of Avandia ever since. Dr. Nissen reacts to the September 23, 2010 FDA Avandia restrictions. Continue reading FDA Avandia heart attack news, Avandia critic reacts to FDA

Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia News | Avandia Safety | Avandia Settlements | Avandia Warning

FDA stops Avandia TIDE trial due to unjustified heart risks

25 September, 2010

FDA stops Avandia TIDE trial due to unjustified risk of stroke and cardiac events.

Act now to make you Avandia settlement claim. FDA drug safety experts concluded that the TIDE trial subjected participants to an unjustified risk of heart disease. All of the regulatory deadlines set by the FDA for completion of the trial have been rescinded. Continue reading FDA stops Avandia TIDE trial due to unjustified heart risks

Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia News | Avandia Safety

FDA reviewing safety of Avandia’s rival diabetes drug Actos

18 September, 2010

The FDA has begun reviewing the safety of the diabetes drug Actos (pioglitazone), after receiving early results from research evaluating the drug’s bladder cancer risk.

While early data from a long-term study demonstrates an increased risk of bladder cancer in patients with the longest exposure and in those having taken the highest cumulative dose of Actos, the FDA has not concluded that Actos increases the risk of bladder cancer. The FDA has no clinical information associating Avandia with bladder cancer. Continue reading FDA reviewing safety of Avandia's rival diabetes drug Actos

Category: Avandia FDA | Avandia News | Avandia Safety | Uncategorized

Drug experts call for UK Avandia recall due to side effects

9 September, 2010

Concerns over Avandia side effects has led an independent panel of drug safety experts in England to call for an Avandia recall.

The Medicines and Healthcare Products Regulatory Agency (MHRA) is the Brittish counterpart to the U.S. FDA. Avandia side effects risks outweigh its benefits, the regulators were advised by the panel. Continue reading Drug experts call for UK Avandia recall due to side effects

Category: Avandia News | Avandia Recall | Avandia Safety | Avandia Side Effects

Avandia heart risks similar to Actos claims new study

28 August, 2010

A new study comparing heart side effects risks of rival diabetes drugs Avandia and Actos suggests both treatments carry similar risks of heart attack, acute heart failure and death.

Researchers at health insurance company WellPoint reviewed the claims records of over 29,000 diabetic clients who took either of the drugs between 2001 and 2005. The study was published on August 24, 2010 in the medical journal, “Circulation: Cardiovascular Quality and Outcomes.” Continue reading Avandia heart risks similar to Actos claims new study

Category: Avandia Cardiovascular Risk | Avandia Lawsuit | Avandia News | Avandia Safety | Avandia Side Effects

Avandia Heart Failure Lawsuit Settlements

25 August, 2010

Heart failure is a condition in which the can’t pump enough blood to meet the body’s needs.

Congestive heart failure (CHF) is a chronic cardiovascular disease process and may cause disability and even death. Use of the Type 2 diabetes drug Avandia has been linked to an increased risk of congestive heart failure (CHF) and death. Continue reading Avandia Heart Failure Lawsuit Settlements

Category: Avandia Cardiovascular Risk | Avandia Lawsuit | Avandia Safety | Congestive Heart Failure

New study links TZDs Actos and Avandia to fracture risk

31 July, 2010

Avandia increases the risk of fractures in women over 50 and in men who also take loop diuretics, according a new study published in the Journal of Clinical Endocrinology & Metabolism.

The new study examined diabetes treatments and fractures using data from the TRIAD study of diabetic patients in managed care settings. Continue reading New study links TZDs Actos and Avandia to fracture risk

Category: Avandia News | Avandia Safety | Avandia Side Effects
Recent Comments
  • SEABEECH: Peace be with you. My dad died at 11:22 on December 21, 201...
  • vertee jackson jr: The company hired to save (GSK) money is using a point syste...
  • E. Tan: I am from the Philippines and my mother, a diabetic for more...
  • A. Held: "Documents released earlier this year by the Senate Finance ...
  • Robert: I was 37 and had to have Quadruple bypass in Oct 2005. I was...